Outcome variables | Control | Intervention | OR (95% CI) | ||
Number | Events (%)* | Number | Events (%)* | ||
Use of antihypertensive drugs | |||||
Baseline | 107 | 63 (58.9) | 103 | 68 (66.0) | 1.36 (0.77 to 2.38) |
2-week follow-up | 105 | 63 (58.9) | 100 | 68 (66.0) | 1.36 (0.77 to 2.38) |
3-month follow-up | 101 | 69 (64.5) | 97 | 67 (65.0) | 1.02 (0.58 to 1.81) |
6-month follow-up | 98 | 62 (57.9) | 95 | 67 (65.0) | 1.35 (0.77 to 2.36) |
Good adherence | |||||
Baseline | 107 | 43 (40.2) | 103 | 48 (46.6) | 1.30 (0.75 to 2.24) |
2-week follow-up | 105 | 44 (41.1) | 100 | 50 (49.5) | 1.35 (0.78 to 2.33) |
3-month follow-up | 101 | 50 (46.7) | 97 | 45 (43.7) | 0.88 (0.51 to 1.52) |
6-month follow-up | 98 | 43 (40.2) | 95 | 45 (43.7) | 1.15 (0.67 to 2.00) |
*Percentages were calculated following the ‘intention-to-treat’ principle.
CI, confidence interval; OR, odds ratio.